US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 21.270
  • -0.190-0.89%
Close Dec 20 16:00 ET
  • 21.270
  • 0.0000.00%
Post 20:01 ET
2.54BMarket Cap18.03P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.48%72.87M
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
92.22%116.05M
109.00%40.08M
Net income from continuing operations
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
Operating gains losses
----
----
----
----
----
----
----
----
--762K
--0
Depreciation and amortization
10.31%9.45M
10.09%9.44M
42.88%9.43M
2,553.83%32.88M
1,386.67%9.14M
1,449.37%8.57M
23,062.16%8.57M
19,311.76%6.6M
545.31%1.24M
1,763.64%615K
Deferred tax
38.44%-8.58M
50.20%-1.61M
-14.94%-1.75M
-460.91%-17.82M
-31.28%883K
-1,592.83%-13.94M
-496.45%-3.24M
-179.91%-1.52M
-47.01%4.94M
-53.19%1.29M
Other non cash items
-101.26%-1.01M
212.31%203K
13.92%221K
1,794.06%83.23M
3,814.29%2.47M
1,816.67%80.5M
-10.96%65K
234.48%194K
1,431.01%4.39M
-21.25%63K
Change In working capital
832.98%26.47M
155.06%8.65M
66.31%-8.65M
-371.86%-37.32M
-28.58%7.65M
-133.80%-3.61M
-1,687.66%-15.7M
-196.40%-25.67M
173.38%13.73M
93.55%10.72M
-Change in receivables
79.17%-1.09M
135.35%3.32M
69.61%-6.98M
-1,027.62%-43.08M
-395.92%-5.47M
-2,201.20%-5.25M
-1,073.47%-9.39M
-483.85%-22.96M
-504.43%-3.82M
-18,466.67%-1.1M
-Change in inventory
-216.72%-2M
558.39%1.94M
-846.79%-4.31M
-544.98%-4.74M
-2,121.10%-6.61M
139.00%1.72M
-1,739.13%-423K
1,241.86%577K
133.08%1.07M
135.54%327K
-Change in prepaid assets
196.96%5.17M
-476.76%-9.81M
-533.51%-1.21M
-617.72%-5.79M
203.26%1.43M
-1,056.55%-5.33M
-392.60%-1.7M
66.07%-191K
-120.29%-807K
-1,894.81%-1.38M
-Change in payables and accrued expense
358.67%24.49M
423.90%13.28M
231.07%3.94M
-5.56%16.62M
41.96%18.39M
-42.18%5.34M
-797.37%-4.1M
27.27%-3.01M
336.46%17.6M
100.74%12.95M
-Change in other current liabilities
-9.30%-94K
-9.52%-92K
-8.54%-89K
-10.10%-338K
-10.26%-86K
-8.86%-86K
-9.09%-84K
-12.33%-82K
-135.53%-307K
0.00%-78K
Cash from discontinued investing activities
Operating cash flow
61.48%72.87M
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
92.22%116.05M
109.00%40.08M
Investing cash flow
Cash flow from continuing investing activities
99.72%-259K
-10K
99.88%-199K
-3,287.12%-293.5M
-38.32M
-70,215.91%-92.82M
0
-162.37M
183.56%9.21M
0
Net PPE purchase and sale
-304.69%-259K
---10K
-168.92%-199K
-696.55%-231K
---93K
---64K
--0
---74K
97.16%-29K
--0
Net intangibles purchase and sale
----
----
----
---81.51M
---2.23M
----
----
----
--0
--0
Net investment purchase and sale
----
----
----
-169.99%-13.47M
--0
----
----
----
292.38%19.24M
--0
Net other investing changes
----
----
----
-1,882.93%-198.29M
---36M
--0
--0
---162.29M
---10M
--0
Cash from discontinued investing activities
Investing cash flow
99.72%-259K
---10K
99.88%-199K
-3,287.12%-293.5M
---38.32M
-70,215.91%-92.82M
--0
---162.37M
183.56%9.21M
--0
Financing cash flow
Cash flow from continuing financing activities
41.01%-5.97M
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
120.80%1.69M
189.19%2.25M
Net common stock issuance
--0
--0
--140.7M
--0
--0
--0
--0
--0
42.87%-6.91M
--0
Proceeds from stock option exercised by employees
1,776.42%3.98M
229.17%2.03M
19.84%1.52M
-70.82%2.79M
-78.35%693K
-94.68%212K
-55.42%617K
27.00%1.27M
133.45%9.57M
367.30%3.2M
Net other financing activities
3.74%-9.95M
-5.17%-874K
-5.00%-1.18M
-1,310.02%-13.65M
-43.25%-1.36M
---10.34M
---831K
---1.12M
-532.68%-968K
-597.06%-948K
Cash from discontinued financing activities
Financing cash flow
41.01%-5.97M
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
120.80%1.69M
189.19%2.25M
Net cash flow
Beginning cash position
110.13%375.69M
109.39%310.41M
-53.87%137.64M
74.05%298.4M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
74.05%298.4M
31.64%171.45M
65.38%256.07M
Current changes in cash
215.26%66.64M
113.76%65.28M
215.07%172.78M
-226.63%-160.76M
-60.63%16.67M
-228.04%-57.82M
-6.15%30.54M
-2,267.58%-150.15M
208.07%126.95M
154.86%42.33M
End cash Position
265.65%442.33M
110.13%375.69M
109.39%310.41M
-53.87%137.64M
-53.87%137.64M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
74.05%298.4M
74.05%298.4M
Free cash flow
312.17%72.61M
108.51%64.13M
164.47%31.73M
-46.68%61.86M
33.07%53.33M
-182.86%-34.22M
17.55%30.75M
41.50%12M
95.48%116.02M
109.44%40.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.48%72.87M108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M92.22%116.05M109.00%40.08M
Net income from continuing operations 242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M
Operating gains losses ----------------------------------762K--0
Depreciation and amortization 10.31%9.45M10.09%9.44M42.88%9.43M2,553.83%32.88M1,386.67%9.14M1,449.37%8.57M23,062.16%8.57M19,311.76%6.6M545.31%1.24M1,763.64%615K
Deferred tax 38.44%-8.58M50.20%-1.61M-14.94%-1.75M-460.91%-17.82M-31.28%883K-1,592.83%-13.94M-496.45%-3.24M-179.91%-1.52M-47.01%4.94M-53.19%1.29M
Other non cash items -101.26%-1.01M212.31%203K13.92%221K1,794.06%83.23M3,814.29%2.47M1,816.67%80.5M-10.96%65K234.48%194K1,431.01%4.39M-21.25%63K
Change In working capital 832.98%26.47M155.06%8.65M66.31%-8.65M-371.86%-37.32M-28.58%7.65M-133.80%-3.61M-1,687.66%-15.7M-196.40%-25.67M173.38%13.73M93.55%10.72M
-Change in receivables 79.17%-1.09M135.35%3.32M69.61%-6.98M-1,027.62%-43.08M-395.92%-5.47M-2,201.20%-5.25M-1,073.47%-9.39M-483.85%-22.96M-504.43%-3.82M-18,466.67%-1.1M
-Change in inventory -216.72%-2M558.39%1.94M-846.79%-4.31M-544.98%-4.74M-2,121.10%-6.61M139.00%1.72M-1,739.13%-423K1,241.86%577K133.08%1.07M135.54%327K
-Change in prepaid assets 196.96%5.17M-476.76%-9.81M-533.51%-1.21M-617.72%-5.79M203.26%1.43M-1,056.55%-5.33M-392.60%-1.7M66.07%-191K-120.29%-807K-1,894.81%-1.38M
-Change in payables and accrued expense 358.67%24.49M423.90%13.28M231.07%3.94M-5.56%16.62M41.96%18.39M-42.18%5.34M-797.37%-4.1M27.27%-3.01M336.46%17.6M100.74%12.95M
-Change in other current liabilities -9.30%-94K-9.52%-92K-8.54%-89K-10.10%-338K-10.26%-86K-8.86%-86K-9.09%-84K-12.33%-82K-135.53%-307K0.00%-78K
Cash from discontinued investing activities
Operating cash flow 61.48%72.87M108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M92.22%116.05M109.00%40.08M
Investing cash flow
Cash flow from continuing investing activities 99.72%-259K-10K99.88%-199K-3,287.12%-293.5M-38.32M-70,215.91%-92.82M0-162.37M183.56%9.21M0
Net PPE purchase and sale -304.69%-259K---10K-168.92%-199K-696.55%-231K---93K---64K--0---74K97.16%-29K--0
Net intangibles purchase and sale ---------------81.51M---2.23M--------------0--0
Net investment purchase and sale -------------169.99%-13.47M--0------------292.38%19.24M--0
Net other investing changes -------------1,882.93%-198.29M---36M--0--0---162.29M---10M--0
Cash from discontinued investing activities
Investing cash flow 99.72%-259K---10K99.88%-199K-3,287.12%-293.5M---38.32M-70,215.91%-92.82M--0---162.37M183.56%9.21M--0
Financing cash flow
Cash flow from continuing financing activities 41.01%-5.97M640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K120.80%1.69M189.19%2.25M
Net common stock issuance --0--0--140.7M--0--0--0--0--042.87%-6.91M--0
Proceeds from stock option exercised by employees 1,776.42%3.98M229.17%2.03M19.84%1.52M-70.82%2.79M-78.35%693K-94.68%212K-55.42%617K27.00%1.27M133.45%9.57M367.30%3.2M
Net other financing activities 3.74%-9.95M-5.17%-874K-5.00%-1.18M-1,310.02%-13.65M-43.25%-1.36M---10.34M---831K---1.12M-532.68%-968K-597.06%-948K
Cash from discontinued financing activities
Financing cash flow 41.01%-5.97M640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K120.80%1.69M189.19%2.25M
Net cash flow
Beginning cash position 110.13%375.69M109.39%310.41M-53.87%137.64M74.05%298.4M-52.76%120.97M-15.23%178.79M-16.89%148.25M74.05%298.4M31.64%171.45M65.38%256.07M
Current changes in cash 215.26%66.64M113.76%65.28M215.07%172.78M-226.63%-160.76M-60.63%16.67M-228.04%-57.82M-6.15%30.54M-2,267.58%-150.15M208.07%126.95M154.86%42.33M
End cash Position 265.65%442.33M110.13%375.69M109.39%310.41M-53.87%137.64M-53.87%137.64M-52.76%120.97M-15.23%178.79M-16.89%148.25M74.05%298.4M74.05%298.4M
Free cash flow 312.17%72.61M108.51%64.13M164.47%31.73M-46.68%61.86M33.07%53.33M-182.86%-34.22M17.55%30.75M41.50%12M95.48%116.02M109.44%40.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data